Search results
Results from the WOW.Com Content Network
Severe nightmares may also be behind somniphobia. Signs and symptoms of sleep anxiety ... Therapy vs. medication. The first line of treatment for somniphobia caused by insomnia is cognitive ...
Furthermore, nightmares contain more scenes of aggression than bad dreams and more unhappy endings. [7] Finally, people experiencing nightmares feel more fear than with bad dreams. [7] The treatment depends on whether or not there is a comorbid PTSD diagnosis. [1] About 4% of American adults are affected. [1]
In 2018, a systematic review and network meta-analysis comparing the efficacy and acceptability of 21 antidepressant drugs showed agomelatine to be one of the most effective and one of only two medications found to be more tolerable than placebo. [14] A meta-analysis found that agomelatine is effective in treating severe depression. Its ...
Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). [7] It is used in the treatment of various conditions, most notably obsessive–compulsive disorder but also many other disorders, including hyperacusis, panic disorder, major depressive disorder, trichotillomania, [8] body dysmorphic disorder [9] [10] [11] and chronic pain. [7]
Trazodone, sold under many brand names, [1] is an antidepressant medication [20] used to treat major depressive disorder, anxiety disorders, and insomnia. [20] It is a phenylpiperazine compound of the serotonin antagonist and reuptake inhibitor (SARI) class.
Triazolam is usually used for short-term treatment of acute insomnia and circadian rhythm sleep disorders, including jet lag.It is an ideal benzodiazepine for this use because of its fast onset of action and short half-life.
A 29-year-old man’s debilitating night terrors were the first sign of rare autoimmune disorder that rapidly progressed, landing him in the intensive care unit in a “catatonic state.” Ben ...
Loprazolam (triazulenone) marketed under many brand names is a benzodiazepine medication. It possesses anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. It is licensed and marketed for the short-term treatment of moderately-severe insomnia. It was patented in 1975 and came into medical use in 1983. [2]